With regard to letter from the Minister of National Revenue on July 31, 2017, that stated “with consideration given to recent advances in technology, adults who independently manage their insulin therapy on a regular basis are unlikely to meet the 14-hours-per-week requirement” and the decision to clawback the disability tax credit from diabetes patients: (a) which section of the Canada Revenue Agency (CRA) recommended this finding; (b) what specific recent advances in technology is the Minister referring to; (c) which stakeholders, if any, were consulted in advance of this change; (d) did any stakeholders object to this recommendation and, if so, which ones; (e) what medical advice did the CRA seek in order to support this finding; (f) does Health Canada consider diabetes to be a serious enough condition in order to meet the 14-hours-per-week requirement; (g) was the Minister of Health consulted in regard to the CRA decision, and if so, was the Minister of Health in favour of the CRA decision; (h) how many diabetics are estimated to be impacted by the CRA decision; and (i) what is the yearly estimated increase in tax revenue as a result of the CRA decision?
In the House of Commons on December 11th, 2017. See this statement in context.